These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7156604)

  • 1. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-tubercular agent injuries to the liver in liver disease].
    Zhang P
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):643-4. PubMed ID: 11477886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
    Blanchon P; Paillas J; Groseille Y; Holler A; Blanchon F
    Ann Med Interne (Paris); 1974 Dec; 125(12):919-22. PubMed ID: 4469954
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy.
    Mansukhani S; Shah I
    Ann Hepatol; 2012; 11(1):96-9. PubMed ID: 22166567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison between two strategies for monitoring hepatic function during antituberculous therapy.
    Singanayagam A; Sridhar S; Dhariwal J; Abdel-Aziz D; Munro K; Connell DW; George PM; Molyneaux PL; Cooke GS; Burroughs AK; Lalvani A; Wickremasinghe M; Kon OM
    Am J Respir Crit Care Med; 2012 Mar; 185(6):653-9. PubMed ID: 22198973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver and antitubercular drug therapy].
    Viroglio AL; Piñeyro JO; Acosta A; Munaro N; Escarguel Malbrán J; Pérez JA
    Rev Fac Cienc Med Cordoba; 1974; 32(1):19-36. PubMed ID: 4458009
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlates of hepatotoxicity and antituberculosis therapy in South Carolina.
    Dowda M; Sy FS; Dowda H; Pozsik CJ
    J S C Med Assoc; 1998 Jan; 94(1):16-20. PubMed ID: 9473867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in reintroducing tuberculosis medications after hepatotoxicity.
    Saukkonen J
    Clin Infect Dis; 2010 Mar; 50(6):840-2. PubMed ID: 20156056
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
    Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
    Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age, sex and alcoholic habit of patients on liver enzymes during antituberculosis chemotherapy.
    Aggarwal NP; Kallan BM; Aggarwal M; Joshi R
    J Indian Med Assoc; 1991 Nov; 89(11):311-2. PubMed ID: 1787318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatic function and antitubercular drugs].
    Fossati C
    Clin Ter; 1978 Sep; 86(5):495-501. PubMed ID: 367684
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatotoxicity and antituberculosis therapy: time to revise UK guidance?
    Walker NF; Kliner M; Turner D; Bhagani S; Cropley I; Hopkins S; Lipman M
    Thorax; 2009 Oct; 64(10):918. PubMed ID: 19786720
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic involvement with tuberculosis-associated immune reconstitution disease.
    Lawn SD; Wood R
    AIDS; 2007 Nov; 21(17):2362-3. PubMed ID: 18090294
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis.
    Pore SM; Shinde K
    J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953
    [No Abstract]   [Full Text] [Related]  

  • 16. [Toxic liver lesions caused by alcohol and chemicals].
    Keiner F
    Med Welt; 1978 Dec; 29(51-52):2004-10. PubMed ID: 723603
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitubercular chemoprevention: hepatotoxicity and therapeutic compliance].
    Hortoneda Giménez M; Alfonso Sánchez JL; Cortés Vizcaíno C; Sabater Pons A
    An Med Interna; 1993 Dec; 10(12):587-9. PubMed ID: 8049323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of some liver function tests routinely performed in early detection of damage to liver parenchyma in patients with pulmonary tuberculosis].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1205-9. PubMed ID: 5139239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatotoxicity of antitubercular drugs. Apropos of 28 cases].
    Sakhri A; Ben Kemla S; Khadraoui M; Cheikh R
    Tunis Med; 2003 Jul; 81(7):488-94. PubMed ID: 14534960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind controlled trial of chemoprophylaxis against tuberculosis in patients with silicosis in Hong Kong.
    Girling DJ
    Bull Int Union Tuberc Lung Dis; 1990-1991; 66 Suppl():13-4. PubMed ID: 1983741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.